Analysis of Clinical, Serological, and Imaging Features of Autoimmune Pancreatitis and a Case-Control Study on Prognostic Factors in Response to Hormone Therapy

Table 4

Comparison of imaging changes between the recurrent group and nonrecurrent group (n (%)).

Index	N	Recurrent group (n = 42)	Nonrecurrent group (n = 64)	χ^2
Salivary gland involvement
Yes	7	3 (42.86)	4 (57.14)	0.032	0.856
None	99	39 (39.39)	60 (60.61)
Lymph node involvement
Yes	14	6 (42.86)	8 (57.14)	0.070	0.790
None	92	36 (39.13)	56 (60.87)
Lung involvement
Yes	3	1 (33.33)	2 (66.67)	0.051	0.821
None	103	41 (39.81)	62 (60.19)
Kidney involvement
Yes	6	2 (33.33)	4 (66.67)	0.105	0.745
None	100	40 (40.00)	60 (60.00)
Extrapancreatic organ involvement
Yes	62	38 (45.16)	24 (54.84)	51.223	<0.001
None	44	4 (31.82)	40 (68.18)